大幸薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2010/02/23 | 1,583 | 1,714 | 1,580 | 1,631 | +33 | +2.1% | 194,900 |
2010/02/22 | 1,591 | 1,627 | 1,560 | 1,598 | +32 | +2% | 73,800 |
2010/02/19 | 1,630 | 1,668 | 1,550 | 1,566 | -66 | -4% | 176,000 |
2010/02/18 | 1,615 | 1,637 | 1,603 | 1,632 | +13 | +0.8% | 78,100 |
2010/02/17 | 1,628 | 1,647 | 1,615 | 1,619 | -28 | -1.7% | 76,400 |
2010/02/16 | 1,607 | 1,659 | 1,605 | 1,647 | +38 | +2.4% | 122,900 |
2010/02/15 | 1,666 | 1,666 | 1,593 | 1,609 | -79 | -4.7% | 209,200 |
2010/02/12 | 1,822 | 1,822 | 1,630 | 1,688 | -134 | -7.4% | 507,900 |
2010/02/10 | 1,885 | 1,895 | 1,805 | 1,822 | -37 | -2% | 109,900 |
2010/02/09 | 1,898 | 1,900 | 1,818 | 1,859 | -50 | -2.6% | 89,200 |
2010/02/08 | 1,930 | 1,965 | 1,909 | 1,909 | -46 | -2.4% | 49,100 |
2010/02/05 | 1,965 | 1,980 | 1,931 | 1,955 | -40 | -2% | 76,500 |
2010/02/04 | 1,997 | 2,013 | 1,984 | 1,995 | -2 | -0.1% | 43,000 |
2010/02/03 | 1,996 | 2,018 | 1,990 | 1,997 | +10 | +0.5% | 42,900 |
2010/02/02 | 1,986 | 2,011 | 1,985 | 1,987 | +3 | +0.2% | 55,200 |
2010/02/01 | 2,016 | 2,020 | 1,980 | 1,984 | -46 | -2.3% | 87,700 |
2010/01/29 | 2,032 | 2,050 | 2,022 | 2,030 | -20 | -1% | 54,800 |
2010/01/28 | 2,070 | 2,070 | 2,035 | 2,050 | +5 | +0.2% | 36,500 |
2010/01/27 | 2,061 | 2,101 | 2,027 | 2,045 | -15 | -0.7% | 72,600 |
2010/01/26 | 2,178 | 2,198 | 2,049 | 2,060 | -70 | -3.3% | 239,500 |
2010/01/25 | 2,040 | 2,130 | 2,015 | 2,130 | +106 | +5.2% | 173,000 |
2010/01/22 | 2,025 | 2,055 | 2,013 | 2,024 | -36 | -1.7% | 61,700 |
2010/01/21 | 2,015 | 2,080 | 2,012 | 2,060 | +36 | +1.8% | 53,900 |
2010/01/20 | 2,024 | 2,050 | 2,021 | 2,024 | +4 | +0.2% | 50,200 |
2010/01/19 | 2,043 | 2,050 | 2,010 | 2,020 | -36 | -1.8% | 79,600 |
2010/01/18 | 2,072 | 2,086 | 2,051 | 2,056 | -21 | -1% | 60,200 |
2010/01/15 | 2,095 | 2,120 | 2,061 | 2,077 | +3 | +0.1% | 79,200 |
2010/01/14 | 2,107 | 2,125 | 2,030 | 2,074 | -45 | -2.1% | 154,600 |
2010/01/13 | 2,164 | 2,185 | 2,100 | 2,119 | -36 | -1.7% | 181,500 |
2010/01/12 | 2,150 | 2,180 | 2,142 | 2,155 | +35 | +1.7% | 168,200 |
2010/01/08 | 2,147 | 2,175 | 2,100 | 2,120 | +23 | +1.1% | 328,600 |
2010/01/07 | 1,940 | 2,099 | 1,933 | 2,097 | +163 | +8.4% | 262,100 |
2010/01/06 | 1,950 | 1,950 | 1,913 | 1,934 | -1 | -0.1% | 53,000 |
2010/01/05 | 1,932 | 1,957 | 1,911 | 1,935 | +5 | +0.3% | 92,500 |
2010/01/04 | 1,922 | 1,950 | 1,902 | 1,930 | +8 | +0.4% | 75,400 |
2009/12/30 | 1,999 | 2,005 | 1,918 | 1,922 | -77 | -3.9% | 254,400 |
2009/12/29 | 2,000 | 2,010 | 1,990 | 1,999 | -1 | -0.1% | 57,000 |
2009/12/28 | 2,020 | 2,020 | 1,995 | 2,000 | +10 | +0.5% | 71,200 |
2009/12/25 | 1,979 | 2,010 | 1,978 | 1,990 | +11 | +0.6% | 97,300 |
2009/12/24 | 2,025 | 2,030 | 1,971 | 1,979 | -31 | -1.5% | 177,000 |
2009/12/22 | 1,963 | 2,040 | 1,963 | 2,010 | +48 | +2.4% | 193,400 |
2009/12/21 | 2,000 | 2,010 | 1,955 | 1,962 | -78 | -3.8% | 244,000 |
2009/12/18 | 2,050 | 2,065 | 1,983 | 2,040 | -25 | -1.2% | 349,900 |
2009/12/17 | 2,115 | 2,140 | 2,055 | 2,065 | -95 | -4.4% | 212,500 |
2009/12/16 | 2,070 | 2,175 | 2,020 | 2,160 | +110 | +5.4% | 284,600 |
2009/12/15 | 2,200 | 2,205 | 2,030 | 2,050 | -155 | -7% | 273,700 |
2009/12/14 | 2,240 | 2,245 | 2,205 | 2,205 | +5 | +0.2% | 85,400 |
2009/12/11 | 2,230 | 2,280 | 2,180 | 2,200 | -20 | -0.9% | 145,900 |
2009/12/10 | 2,195 | 2,340 | 2,170 | 2,220 | -5 | -0.2% | 419,700 |
2009/12/09 | 2,365 | 2,365 | 2,150 | 2,225 | -140 | -5.9% | 567,200 |
3751~
3800
件表示中 / 3978件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大幸薬品 | 36,700円 | +0.1% | -70.9% | 0.00% | 61.37倍 | 2.31倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
ステムリム | 32,600円 | - | - | 0.00% | - | 3.00倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
扶桑薬 | 210,200円 | +1.6% | -12.7% | 4.28% | 7.81倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
CANBAS | 96,600円 | - | - | 0.00% | - | 6.18倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
キッズバイオ | 37,000円 | - | - | 0.00% | - | 13.17倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞(SHED)用いた再生医療に力 |
市場注目の銘柄
チャート関連のコラム